• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Visioneering Technologies

Sanuwave confirms acting CEO Richardson as company head | Personnel Moves – December 12, 2018

December 12, 2018 By Fink Densford

Sanuwave said late last month that it lifted acting CEO and board chair Kevin Richardson to a permanent position in the corner office. Richardson joined the Suwanee, Ga.-based company in 2009 as board chair, and has served as acting CEO since 2014. He also served as managing partner of investment management firm Prides Capital from […]

Filed Under: Business/Financial News, Featured Tagged With: Bose Corp., Bristol-Myers Squibb Co., Common Sensing, glympsebio, INSIGHTEC, Insulet, IsoRay, Merck, novadipbiosciences, Owens and Minor, rmsmedical, Sanuwave, Visioneering Technologies, Zimmer Biomet

Senseonics CFO Elsey to retire | Personnel Moves – December 4, 2018

December 4, 2018 By Fink Densford

Senseonics (NYSE:SENS) said yesterday that its CFO R. Elsey is retiring for the company, and that it has begun searching for a permanent replacement. The Germantown, Md.-based company said that Elsey will stay on until a replacement is appointed, and remain on in an advisory role through to the completion of the company’s 2018 fiscal […]

Filed Under: Business/Financial News Tagged With: Accuray Inc., avitamedical, Baxter, Hillrom, Senseonics, ViewRay Inc., Visioneering Technologies

Visioneering Tech touts NaturalVue contact lens pediatric myopia study

November 8, 2018 By Fink Densford

Visioneering Technologies Inc yesterday released results from a pediatric study of its NaturalView multifocal contact lens intended to treat myopia, touting Results from the trial were presented by study lead Dr. Thomas Aller of the UC Berkeley School of Optometry at the American Academy of Optometry Conference in San Antonio this week. In the trial, […]

Filed Under: Clinical Trials, Optical/Ophthalmic Tagged With: Visioneering Technologies

Halyard Health taps former Acelity head Woody for CEO | Personnel Moves July 5, 2017

July 5, 2017 By Fink Densford

Halyard Health (NYSE:HYH) said late last month it tapped former Acelity prez & CEO Joseph Woody as its new chief executive officer, replacing a retiring Robert Abernathy. Woody will also assume a seat on the board of directors, with former CEO Abernathy continuing on as board chair, the Alpharetta, Ga.-based company said. “On behalf of the […]

Filed Under: Business/Financial News Tagged With: Acelity, Avanos Medical (formerly Halyard Health), Cardiovascular Systems Inc., Conventus Orthopaedics, depuysynthes, IsoRay, Johnson and Johnson, Lumicell, Merck, Nevro Corp., Olympus, Personnel Moves, Raumedic, Sanofi-Aventis, SOLOS Endoscopy Inc., Stryker, Visioneering Technologies

Visioneering Technologies closes $26m IPO

March 16, 2017 By Fink Densford

Visioneering Technologies Inc said today it closed a $25.5 million (AUD $33.3 million) initial public offering in Australia, with funds slated to support its NaturalVue multifocal contact lenses. In the offering, the Alpharetta, Ga.-based company floated approximately 79.4 million shares of Class A common stock at 32¢ (AUD 42¢) per share, with strong support from Australian […]

Filed Under: Initial Public Offering (IPO), Optical/Ophthalmic Tagged With: Visioneering Technologies

Contact lens maker VTI plans IPO Down Under

March 2, 2017 By Sarah Faulkner

Visioneering Technologies this week priced its A$33.3 million initial public offering on the Australian Securities Exchange. The U.S.-based contact lens maker said it’s offering 79.4 million shares of its Class A common stock priced at ¢42 apiece. The company plans to use the net proceeds from the IPO to provide capital as VTI broadens the U.S. […]

Filed Under: Initial Public Offering (IPO), Optical/Ophthalmic, Wall Street Beat Tagged With: Visioneering Technologies

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy